Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Orlistat
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Orlistat 120mg capsules
0405010P0AAAAAA
|
Orlistat | Orlistat | Central Nervous System | 128,837 |
|
Orlistat 60mg capsules
0405010P0AAABAB
|
Orlistat | Orlistat | Central Nervous System | 1,325 |
|
Xenical 120mg capsules
0405010P0BBAAAA
|
Xenical | Orlistat | Central Nervous System | 447 |
|
Alli 60mg capsules
0405010P0BCAAAB
|
Alli | Orlistat | Central Nervous System | 9 |
|
Orlos 60mg capsules
0405010P0BEAAAB
|
Orlos | Orlistat | Central Nervous System | 4 |
|
Beacita 120mg capsules
0405010P0BDAAAA
|
Beacita | Orlistat | Central Nervous System | 3 |
|
Alli 27mg chewable tablets
0405010P0BCABAC
|
Alli | Orlistat | Central Nervous System | No data available |
|
Orlistat 27mg chewable tablets
0405010P0AAACAC
|
Orlistat | Orlistat | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.